Tenapanor
spdr s&p biotech,ishares biotechnology,ardelyx
['ardelyx', '$ibb', '$xbi', '$ardx']
$ardx ardelyx reveals promising results for tenapanor, a first-in-class treatment for ibs-c in adults, at ddw 2023 more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt